413 related articles for article (PubMed ID: 24787686)
1. [Treatment of cryoglobulinemic vasculitis associated with hepatitis C virus infection].
Retamozo S; Brito-Zerón P; Ramos-Casals M
Med Clin (Barc); 2015 May; 144(9):410-7. PubMed ID: 24787686
[TBL] [Abstract][Full Text] [Related]
2. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
[TBL] [Abstract][Full Text] [Related]
3. Cryoglobulinemic disease.
Retamozo S; Brito-Zerón P; Bosch X; Stone JH; Ramos-Casals M
Oncology (Williston Park); 2013 Nov; 27(11):1098-1105, 1110-6. PubMed ID: 24575538
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis C Virus-Induced Cryoglobulinemic Vasculitis].
Minami Y; Kudo M
Brain Nerve; 2018 Feb; 70(2):133-137. PubMed ID: 29433114
[TBL] [Abstract][Full Text] [Related]
5. [Cryoglobulinemic vasculitis].
Specker C; Passens D; Schlaak J
Z Rheumatol; 2022 May; 81(4):300-304. PubMed ID: 35258723
[TBL] [Abstract][Full Text] [Related]
6. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
Rutledge SM; Chung RT; Sise ME
Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
[TBL] [Abstract][Full Text] [Related]
8. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
Dammacco F; Lauletta G; Vacca A
Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis.
Lo KY; Chen CY; Lee CS
Ren Fail; 2009; 31(2):149-52. PubMed ID: 19212913
[TBL] [Abstract][Full Text] [Related]
10. Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).
Quartuccio L; Bortoluzzi A; Scirè CA; Marangoni A; Del Frate G; Treppo E; Castelnovo L; Saccardo F; Zani R; Candela M; Fraticelli P; Mazzaro C; Renoldi P; Scaini P; Filippini DA; Visentini M; Scarpato S; Giuggioli D; Mascia MT; Sebastiani M; Zignego AL; Lauletta G; Fiorilli M; Casato M; Ferri C; Pietrogrande M; Pioltelli PE; De Vita S; Monti G; Galli M
Clin Rheumatol; 2023 Feb; 42(2):359-370. PubMed ID: 36169798
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
[TBL] [Abstract][Full Text] [Related]
12. Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature.
Giuggioli D; Manfredi A; Lumetti F; Sebastiani M; Ferri C
Semin Arthritis Rheum; 2015 Apr; 44(5):518-526. PubMed ID: 25547031
[TBL] [Abstract][Full Text] [Related]
13. Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies.
Knight GB; Gao L; Gragnani L; Elfahal MM; De Rosa FG; Gordon FD; Agnello V
Arthritis Rheum; 2010 Jul; 62(7):2152-9. PubMed ID: 20506150
[TBL] [Abstract][Full Text] [Related]
14. Cryoglobulinemic vasculitis.
Ferri C; Mascia MT
Curr Opin Rheumatol; 2006 Jan; 18(1):54-63. PubMed ID: 16344620
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia.
Karlsberg PL; Lee WM; Casey DL; Cockerell CJ; Cruz PD
Arch Dermatol; 1995 Oct; 131(10):1119-23. PubMed ID: 7574826
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.
Fabrizi F; Plaisier E; Saadoun D; Martin P; Messa P; Cacoub P
Am J Kidney Dis; 2013 Apr; 61(4):623-37. PubMed ID: 23102733
[TBL] [Abstract][Full Text] [Related]
17. Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.
Retamozo S; Díaz-Lagares C; Bosch X; Bové A; Brito-Zerón P; Gómez ME; Yagüe J; Forns X; Cid MC; Ramos-Casals M
Medicine (Baltimore); 2013 Sep; 92(5):273-284. PubMed ID: 23974248
[TBL] [Abstract][Full Text] [Related]
18. HCV-Related Rheumatic Manifestations and Therapeutic Strategies.
Sebastiani M; Giuggioli D; Colaci M; Fallahi P; Gragnani L; Antonelli A; Zignego AL; Ferri C
Curr Drug Targets; 2017; 18(7):803-810. PubMed ID: 26343108
[TBL] [Abstract][Full Text] [Related]
19. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S
Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis associated cryoglobulinemia].
Pischke S; Cornberg M; Manns MP
Internist (Berl); 2008 Mar; 49(3):297-304. PubMed ID: 18327517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
